(Q42924831)

11 November 2017

title

Chemical probes of Escherichia coli uncovered through chemical-chemical interaction profiling with compounds of known biological activity (English)

1 reference

11 November 2017

Chemical Probes of Escherichia coli Uncovered through Chemical-Chemical Interaction Profiling with Compounds of Known Biological Activity (English)

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

2 July 2024

1 reference

Maya A. Farha

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20797614

2 July 2024

Eric D. Brown

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20797614

2 July 2024

language of work or name

1 reference

1 August 2010

1 reference

11 November 2017

27 August 2010

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20797614

full work available at URL

2 July 2024

https://api.elsevier.com/content/article/PII:S1074552110002504?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

https://api.elsevier.com/content/article/PII:S1074552110002504?httpAccept=text/plain

2 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

2 July 2024

published in

Chemistry and Biology

1 reference

11 November 2017

volume

17

1 reference

11 November 2017

issue

8

1 reference

11 November 2017

page(s)

852-862

1 reference

Reproducibility of the microdilution checkerboard method for antibiotic synergy

11 November 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1128/AAC.37.3.613

Chemical genetic approaches for the elucidation of signaling pathways

1

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Yeast genome-wide drug-induced haploinsufficiency screen to determine drug mode of action

2 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

2 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Target identification in chemical genetics: the (often) missing link

2 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Analysis of gene control signals by DNA fusion and cloning in Escherichia coli

2 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Are essential genes really essential?

2 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Stages of polymyxin B interaction with the Escherichia coli cell envelope

2 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

A Staphylococcus aureus fitness test platform for mechanism-based profiling of antibacterial compounds

2 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli

2 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Genetic basis for activity differences between vancomycin and glycolipid derivatives of vancomycin.

2 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Cluster analysis and display of genome-wide expression patterns

2 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria

2 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

High-throughput assays for promiscuous inhibitors.

2 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

In vitro bactericidal activity of daptomycin against staphylococci

2 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Genomic profiling of drug sensitivities via induced haploinsufficiency.

2 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Multidrug-resistant Gram-negative infections: what are the treatment options?

2 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

MreB actin-mediated segregation of a specific region of a bacterial chromosome

2 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast

2 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

The chemical genomic portrait of yeast: uncovering a phenotype for all genes

2 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry

2 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Topoisomerase IV is a target of quinolones in Escherichia coli

2 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolates

2 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

High-order combination effects and biological robustness

2 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Combination chemical genetics

2 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Multicopy suppressors for novel antibacterial compounds reveal targets and drug efflux susceptibility

2 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin

2 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Reverse engineering of industrial pharmaceutical-producing actinomycete strains using DNA microarrays.

2 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes

2 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening

2 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Rationale for use of antimicrobial combinations

2 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Predicting synthetic rescues in metabolic networks

2 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Synergy of fosmidomycin (FR-31564) and other antimicrobial agents

2 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways

2 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targeting.

2 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Chemical biology and the limits of reductionism.

2 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Development of a virtual screening method for identification of "frequent hitters" in compound libraries

2 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Trimethoprim-sulfamethoxazole

2 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Triclosan: a widely used biocide and its link to antibiotics

2 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Identification and Prediction of Promiscuous Aggregating Inhibitors among Known Drugs

2 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus

2 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Studies on the mechanism by which cyanine dyes measure membrane potential in red blood cells and phosphatidylcholine vesicles.

2 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Chemical genetics: ligand-based discovery of gene function

2 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition

2 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Global mapping of the yeast genetic interaction network

2 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Recognizing molecules with drug-like properties

2 July 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Networks from drug-drug surfaces

2 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Functional classification of drugs by properties of their pairwise interactions.

2 July 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

Multi-target therapeutics: when the whole is greater than the sum of the parts

2 July 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

High-throughput screening of model bacteria

2 July 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

High throughput screening identifies novel inhibitors of Escherichia coli dihydrofolate reductase that are competitive with dihydrofolate

2 July 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.CHEMBIOL.2010.06.008

2 July 2024

Identifiers

1 reference

11 November 2017

1 reference